Literature DB >> 6105837

Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain interface.

J E Hardebo, C Owman.   

Abstract

The integrity of the endothelial cell lining of the cerebrovascular bed constitutes a morphological blood-brain barrier mechanism to neurotransmitter monoamines. Circulating monoamines are prevented from entering the brain primarily at the luminal membrane of the endothelial ling. The small percentage of amines that may pass this membrane is deaminated within the endothelial cells and pericytes of brain microvessels (capillaries, venules, and small veins) and, in the case of large parenchymal and pial vessels, in the smooth muscle layers, where O-methylation also takes place. In the choroid plexus a corresponding deamination and O-methylation takes place in the epithelial cells. The presence of these enzymes constitutes a further, enzymatic, blood-brain barrier in the brain vessels for these monoamines. The monoamine precursors L-3,4-dihydroxyphenylalanine (L-dopa) and L-5-hydroxytryptophan readily pass from the luminal endothelial cell membrane but are trapped by another enzymatic barrier mechanism. Within the endothelial cells and pericytes of the microvasculature, these compounds are decarboxylated to their corresponding amines and then immediately deaminated. One clinical implication of these enzymatic barrier mechanisms is the use of decarboxylase and monoamine oxidase inhibitors as adjuncts to L-dopa treatment of Parkinson disease; these substances facilitate the entry of L-dopa into brain and thus increase the amount of dopamine available at receptor sites. A brief hypertensive or hypertonic stimulus can transiently open the blood-brain barrier through an effect on endothelial cell linings. High circulating concentrations of monoamines can also open the morphological barrier, but probably only indirectly by inducing an acute rise in systemic blood pressure. Once the barrier is open, systemically administered monoamines enter the brain parenchyma, where they can induce pronounced changes in cerebral blood flow and metabolism.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6105837     DOI: 10.1002/ana.410080102

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  37 in total

Review 1.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

2.  Adrenergic receptors coupled to adenylate cyclase in human cerebromicrovascular endothelium.

Authors:  F Bacic; R M McCarron; S Uematsu; M Spatz
Journal:  Metab Brain Dis       Date:  1992-09       Impact factor: 3.584

3.  Improving the oral bioavailability of beneficial polyphenols through designed synergies.

Authors:  Arjan Scheepens; Kee Tan; James W Paxton
Journal:  Genes Nutr       Date:  2009-10-20       Impact factor: 5.523

Review 4.  Pathophysiology of the blood-brain barrier.

Authors:  K Selmaj
Journal:  Springer Semin Immunopathol       Date:  1996

Review 5.  Emotional Modulation of Learning and Memory: Pharmacological Implications.

Authors:  Ryan T LaLumiere; James L McGaugh; Christa K McIntyre
Journal:  Pharmacol Rev       Date:  2017-07       Impact factor: 25.468

Review 6.  Regulation of memory - from the adrenal medulla to liver to astrocytes to neurons.

Authors:  Paul E Gold
Journal:  Brain Res Bull       Date:  2014-01-07       Impact factor: 4.077

Review 7.  Forgetfulness during aging: an integrated biology.

Authors:  Paul E Gold; Donna L Korol
Journal:  Neurobiol Learn Mem       Date:  2014-03-24       Impact factor: 2.877

8.  The effect of ovariectomy and estrogen on penetrating brain arterioles and blood-brain barrier permeability.

Authors:  Marilyn J Cipolla; Julie A Godfrey; Marchien J Wiegman
Journal:  Microcirculation       Date:  2009-11       Impact factor: 2.628

Review 9.  The serotonin system in autism spectrum disorder: From biomarker to animal models.

Authors:  C L Muller; A M J Anacker; J Veenstra-VanderWeele
Journal:  Neuroscience       Date:  2015-11-11       Impact factor: 3.590

10.  Astrocytic glucose-6-phosphatase and the permeability of brain microsomes to glucose 6-phosphate.

Authors:  R J Forsyth; K Bartlett; A Burchell; H M Scott; J A Eyre
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.